Background: Venous thromboembolism (VTE) is a rare side effect of hormonal therapy in transgender persons. Prothrombotic genetic variants can increase this risk. For this reason, previous VTE and/or genetic thrombophilia may be considered by some as contraindications to hormonal treatment. Aim: To formulate directions for clinical practice about the indications for thrombophilia screening and when to consider combination therapy of therapeutic anticoagulation and hormonal treatment as a safe alternative to withholding hormonal treatment. Methods: We conducted a literature search and describe a case series. All adult patients with gender dysphoria and a known prothrombotic genetic variant or history of VTE were invited by letter to participa...
In hypogonadal/postmenopausal individuals, hormone therapy has been associated with an increased ris...
In our sequential studies of 67 and 21 patients, testosterone therapy (TT) interacted with thromboph...
This review examines the impact of gender affirming hormone therapy used in the transgendered and no...
BACKGROUND: Transgender women are female individuals who were recorded men at birth based on natal s...
Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy. However, data sh...
Summary. Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated ...
Background: The transgender population that uses gender-affirming hormone therapy (GAHT) is rapidly ...
Administration of cross-sex hormones to male-to-female transsexual subjects, usually oestrogens + of...
Introduction: Some providers report concern for the safety of transgender hormone therapy (HT). Meth...
OBJECTIVE:To assess the association between risk of venous thromboembolism and use of different type...
The incidence of pediatric venous thromboembolism (VTE) has been increasing in the past few decades ...
Gender-affirming treatment of transgender people requires a multidisciplinary approach in which endo...
Abstract: The risk of venous thromboembolism (VTE) varies throughout a woman’s life and is associate...
AbstractIntroductionSome providers report concern for the safety of transgender hormone therapy (HT)...
Thrombophilia or hypercoagulable state is a clinical condition characterized by a tendency to develo...
In hypogonadal/postmenopausal individuals, hormone therapy has been associated with an increased ris...
In our sequential studies of 67 and 21 patients, testosterone therapy (TT) interacted with thromboph...
This review examines the impact of gender affirming hormone therapy used in the transgendered and no...
BACKGROUND: Transgender women are female individuals who were recorded men at birth based on natal s...
Introduction: Venous thromboembolism (VTE) is a potential risk of estrogen therapy. However, data sh...
Summary. Hormone replacement therapy (HRT) increases the risk of venous thrombosis. We investigated ...
Background: The transgender population that uses gender-affirming hormone therapy (GAHT) is rapidly ...
Administration of cross-sex hormones to male-to-female transsexual subjects, usually oestrogens + of...
Introduction: Some providers report concern for the safety of transgender hormone therapy (HT). Meth...
OBJECTIVE:To assess the association between risk of venous thromboembolism and use of different type...
The incidence of pediatric venous thromboembolism (VTE) has been increasing in the past few decades ...
Gender-affirming treatment of transgender people requires a multidisciplinary approach in which endo...
Abstract: The risk of venous thromboembolism (VTE) varies throughout a woman’s life and is associate...
AbstractIntroductionSome providers report concern for the safety of transgender hormone therapy (HT)...
Thrombophilia or hypercoagulable state is a clinical condition characterized by a tendency to develo...
In hypogonadal/postmenopausal individuals, hormone therapy has been associated with an increased ris...
In our sequential studies of 67 and 21 patients, testosterone therapy (TT) interacted with thromboph...
This review examines the impact of gender affirming hormone therapy used in the transgendered and no...